Long-Term Antibody Persistence at 1, 3 and 5 Years After a Fourth Dose of GSK Biologicals' Hib-MenCY-TT Vaccine Compared to ActHIB

Clinical trial NCT00359983 · COMPLETED

Trial details

NCT number: NCT00359983
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neisseria Meningitidis Haemophilus Influenzae Type b

Start date: 2006-09-01
Primary completion: 2007-11-01
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.